All articles by Srivani Venna

1. EUSA Pharma wins FDA approval for trial of siltuximab to treat ARDS

   EUSA Pharma has secured approval from the US Food & Drug Administration (FDA) for a Phase III clinical trial protocol…
   Read More…

   2 Jul
2. Trialbee and Datavant to partner for clinical trial recruitment

   Global technology provider Trialbee has announced a partnership with Datavant to power patient-centric clinical trial recruitment and engagement. Under the…
   Read More…

   24 Jun
3. Xeris reports positive topline results from trial of XP-3924

   Xeris Pharmaceuticals has reported positive topline results from the trial of novel Xerisol pramlintide-insulin co-formulation XP-3924 in adult patients with…
   Read More…

   19 Jun
4. Seattle Genetics initiates trial of SEA-TGT for solid tumours

   Seattle Genetics has dosed the first patient in a Phase I trial SEA-TGT, an anti-TIGIT antibody used for the treatment…
   Read More…

   19 Jun
5. Pfizer and Sangamo report positive data from hemophilia A trial

   Pfizer and Sangamo Therapeutics have reported positive follow-up data from the Phase I/II Alta study of giroctocogene fitelparvovec (PF-07055480) to…
   Read More…

   19 Jun
6. Humanigen reports positive results from lenzilumab Covid-19 study

   Humanigen has reported positive data from the first clinical use of lenzilumab, its humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF)…
   Read More…

   15 Jun
7. PanCAN selects Seven Bridges for pancreatic cancer research

   Patient advocacy organisation Pancreatic Cancer Action Network (PanCAN) has selected Seven Bridges to build a customised, integrated health data platform…
   Read More…

   12 Jun
8. Indian Health Ministry issues draft rules for new Covid-19 drugs

   The Indian Health Ministry has issued a draft notification for ‘compassionate use’ of any unapproved drug that is in the…
   Read More…

   8 Jun
9. VirTrial unveils virtual site monitoring solution for clinical trials

   VirTrial has unveiled a new service called Virtual Pre-Site to enable virtual site monitoring visits in the clinical trials industry….
   Read More…

   27 May
10. Axcella announces positive results from study of NAFLD treatment

    Biotechnology company Axcella has announced positive top-line data from the AXA1125-003 clinical study assessing the impact of AXA1125 and AXA1957…
    Read More…

    7 May